Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 21, 2012 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Initiates Phase I/II Clinical Trial in Dry Age-Related Macular Degeneration

NEWARK, Calif., June 21, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced initiation of a Phase I/II clinical trial of the Company's proprietary HuCNS-SC® product candidate...
May 17, 2012 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Reports Positive Interim Safety Data From Spinal Cord Injury Trial

NEWARK, Calif., May 17, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced completion of the first planned interim safety review of the Company's Phase I/II spinal cord injury...
May 10, 2012 16:02 ET | Source: StemCells, Inc.

StemCells, Inc. Reports First Quarter 2012 Financial Results and Provides Business Update

NEWARK, Calif., May 10, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
May 09, 2012 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. to Provide Progress Report on Spinal Cord Injury Trial at the Interdependence 2012 Global SCI Conference Co-Sponsored by the Rick Hansen Institute and the Rick Hansen Foundation

NEWARK, Calif., May 9, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) today announced that Armin Curt, MD, FRCPC, Professor and Chairman, Spinal Cord Injury Center at the University of Zurich,...
May 07, 2012 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Webcast to Discuss First Quarter 2012 Financial Results and Business Update

NEWARK, Calif., May 7, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
April 02, 2012 06:00 ET | Source: StemCells, Inc.

StemCells, Inc's Milestone Clinical Trial in Pelizaeus-Merzbacher Disease Shows Evidence of Myelination Following Human Neural Stem Cell Transplantation

Trial Provides Proof-of-Concept for Cell-Based Therapy in a Myelination Disorder Company to Host Conference Call Today to Discuss Summary Results NEWARK, Calif., April 2, 2012 (GLOBE NEWSWIRE)...
March 30, 2012 14:15 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Webcast to Discuss Pelizaeus-Merzbacher Disease Clinical Trial Results

NEWARK, Calif., March 30, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) announced today that it will host a conference call and webcast to discuss results from its Phase I clinical trial in...
March 20, 2012 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Grants genOway Exclusive License to Gene Insertion Technology for Genetically Engineered Mice

NEWARK, Calif., March 20, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM) and genOway (NYSE:ALGEN) announced today that they have entered into a license agreement under which StemCells has...
March 13, 2012 16:05 ET | Source: StemCells, Inc.

StemCells, Inc. Reports Fourth Quarter and Year End 2011 Financial Results and Provides Business Update

NEWARK, Calif., March 13, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...
March 09, 2012 09:00 ET | Source: StemCells, Inc.

StemCells, Inc. Announces Webcast to Discuss 2011 Financial Results and Business Update

NEWARK, Calif., March 9, 2012 (GLOBE NEWSWIRE) -- StemCells, Inc. (Nasdaq:STEM), a leading stem cell company developing and commercializing novel cell-based therapeutics and tools for use in stem...